143 related articles for article (PubMed ID: 10481432)
1. [Progress in the therapy of rheumatism].
Heinzl S
Med Monatsschr Pharm; 1999 Aug; 22(8):225. PubMed ID: 10481432
[No Abstract] [Full Text] [Related]
2. New perspectives for nonsteroidal antiinflammatory therapy.
de Brum-Fernandes AJ
J Rheumatol; 1997 Feb; 24(2):246-8. PubMed ID: 9034978
[No Abstract] [Full Text] [Related]
3. Is there anything else we could possibly need to know about COX-2 selective inhibitor drugs?
Davis P; Juby A; Robertson S; Richard N
J Rheumatol; 2004 May; 31(5):847-8. PubMed ID: 15124241
[No Abstract] [Full Text] [Related]
4. Introduction to "nimesulide: beyond COX-2".
Warner TD
Clin Exp Rheumatol; 2001; 19(1 Suppl 22):S1-2. PubMed ID: 11296542
[No Abstract] [Full Text] [Related]
5. Controversies in COX-2 inhibitor therapy. Introduction.
Abramson SB
Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S1-2. PubMed ID: 11695245
[No Abstract] [Full Text] [Related]
6. Basic biology and clinical application of specific cyclooxygenase-2 inhibitors.
Crofford LJ; Lipsky PE; Brooks P; Abramson SB; Simon LS; van de Putte LB
Arthritis Rheum; 2000 Jan; 43(1):4-13. PubMed ID: 10643694
[TBL] [Abstract][Full Text] [Related]
7. Progress in the treatment of rheumatic disease.
Gause A
Nephrol Dial Transplant; 2003 Jan; 18(1):13-6. PubMed ID: 12480952
[No Abstract] [Full Text] [Related]
8. Characteristics of COX2 inhibitors questioned.
Petit-Zeman S
Nat Rev Drug Discov; 2004 Sep; 3(9):726-7. PubMed ID: 15368654
[No Abstract] [Full Text] [Related]
9. [Progress in the study of cyclooxygenase].
Zhu H; Yang ZM
Sheng Li Ke Xue Jin Zhan; 2004 Jan; 35(1):81-3. PubMed ID: 15127608
[No Abstract] [Full Text] [Related]
10. Treatment of rheumatic diseases in the elderly.
Luggen M
Geriatr Nurs; 2001; 22(3):118-9. PubMed ID: 11410761
[No Abstract] [Full Text] [Related]
11. Treatment of rheumatoid arthritis--we're getting closer.
Kushner I; Ballou SP
J Rheumatol; 1999 Nov; 26(11):2291-3. PubMed ID: 10555878
[No Abstract] [Full Text] [Related]
12. [Selective inhibitors of cyclooxygenase-2: new perspectives of human diseases management].
Nasonov EL; Tsvetkova ES; Tov NL
Ter Arkh; 1998; 70(5):8-14. PubMed ID: 9644734
[No Abstract] [Full Text] [Related]
13. [COX-2 inhibitors: current status and outlook].
Dannhardt G; Hahn L
Pharm Unserer Zeit; 2000 Mar; 29(2):100-6. PubMed ID: 10763335
[No Abstract] [Full Text] [Related]
14. Cyclooxygenase 2 inhibitors and thrombogenicity production: comment on the article by Crofford et al.
Sperling R; Braunstein N; Melin J; Reicin A
Arthritis Rheum; 2001 May; 44(5):1229-30. PubMed ID: 11352260
[No Abstract] [Full Text] [Related]
15. [The use of non-steroidal anti inflammatory drugs (NSAIDs)--COX-2 inhibitors].
Tishler M; Langevetiz P; Nesher G
Harefuah; 2002 Oct; 141(10):920-1. PubMed ID: 12420601
[No Abstract] [Full Text] [Related]
16. [Topical pharmacology. COX-2 inhibitors].
Heinzl S
Med Monatsschr Pharm; 1999 Oct; 22(10):298-304. PubMed ID: 10540801
[No Abstract] [Full Text] [Related]
17. Thalidomide, cyclooxygenase-2, and angiogenesis: potential for therapy.
Onn A; Tseng JE; Herbst RS
Clin Cancer Res; 2001 Nov; 7(11):3311-3. PubMed ID: 11705841
[No Abstract] [Full Text] [Related]
18. COX-2 and COX-2 enzyme inhibition.
Conti P
Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):I-II. PubMed ID: 14552697
[No Abstract] [Full Text] [Related]
19. [The cardiovascular safety of cyclooxygenase-2 (COX-2) inhibitors].
Hasdai D; Gottlieb S; Godbourt U; Hod H; Kaluski E
Harefuah; 2002 Oct; 141(10):922-4. PubMed ID: 12420602
[No Abstract] [Full Text] [Related]
20. Bases for a spinal analgesic action of cyclooxygenase inhibitors.
Vanegas H
Proc West Pharmacol Soc; 2002; 45():225-7. PubMed ID: 12434585
[No Abstract] [Full Text] [Related]
[Next] [New Search]
